This is the authors' abstract. We don't add key points for this paper.
The coronavirus disease 2019 (COVID-19) pandemic made daily news of deaths. According to several studies, a significant number of deaths due to COVID-19 resulted from secondary bacterial infections. Consequently, antimicrobials are important tools in helping to defend against mortality in patients with COVOD-19. It should be noted that, antimicrobial resistance (AMR) is now estimated to cause notable global deaths. Points to consider that proportion of COVID-19 cases that are prescribed antibiotics are unclear and may be associated with patient injury and AMR. Thus, the aim of the current review was to focus on the role of antibiotic therapy in the treating of COVID-19.
No takes yet. Share an insight, caveat, or question.
Afshar et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: